Vitamin D therapy of osteoporosis: Plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy

Calcified Tissue International

Volumn 65, Issue 4, 1999, Pages 295-306

  Lau, K H W ^a   Baylink, D J ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alfacalcidol therapy (human); Calcitriol therapy; Osteoporosis; Vitamin D therapy

Indexed keywords

ALFACALCIDOL; CALCITRIOL; PARATHYROID HORMONE; VITAMIN D; VITAMIN D DERIVATIVE;

ADULT; AGED; CALCIUM ABSORPTION; CONFERENCE PAPER; DOSE CALCULATION; DRUG EFFECT; FEMALE; HIGH RISK POPULATION; HUMAN; INTESTINE ABSORPTION; MALE; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

AGING; ANIMALS; CALCITRIOL; HORMONE REPLACEMENT THERAPY; HUMANS; HYDROXYCHOLECALCIFEROLS; OSTEOPOROSIS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 0032887590     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002239900702     Document Type: Conference Paper

References (94)

1. 47Ca absorption in postmenopausal osteoporosis. J Clin Invest 44:1960-1967
2. Bullamore JR, Gallagher JC, Wilkinson R, Nordin BEC, Marshall DH (1970) Effect of age on calcium absorption. Lancet ii:535-537
3. Nordin BE, Wilkinson R, Marshall DH, Gallagher JC, Williams A, Peacock M (1976) Calcium absorption in the elderly. Calcif Tissue Res 21(suppl):442-451
4. Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HF (1979) Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. J Clin Invest 64: 729-736
5. Heaney RP, Barger-Lux MJ, Dowell MS, Chen TC, Holick MF (1997) Calcium absorptive effects of vitamin D and its major metabolites. J Clin Endocrinol Metab 82:4111-4116
6. Francis RM, Peacock M (1987) Local action of oral 1,25-dihydroxycholecalciferol on calcium absorption in osteoporosis. Am J Clin Nutr 46:315-318
7. Brazier M, Kamel S, Maamer M, Agbomson F, Elesper I, Garabedian M, Desmet G, Sebert JL (1995) Markers of bone remodeling in the elderly subject: effects of vitamin D insufficiency and its correction. J Bone Miner Res 10:1753-1761
8. Baker MR, Peacock M, Nordin BEC (1980) The decline in vitamin D status with age. Ageing 9:249-252
9. Tsai K-S, Heath H III, Kumar R, Riggs BL (1984) Impaired vitamin D metabolism with aging in women: possible role in pathogenesis of senile osteoporosis. J Clin Invest 73:1668-1672
10. Lips P, Wiersinga A, van Ginkel FC, Jongen MJ, Netelenbos JC, Hackeng WH, Delmas PD, van der Vijgh WJ (1988) The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J Clin Endocrinol Metab 67:644-650
11. Lips P, Netelenbos JC, Jongen MJM, van Ginkel FC, Althuis AL, van Schaik CL, van der Vijgh WJ, Vermeiden JP, van der Meer C (1982) Histomorphometric profile and vitamin D status in patients with femoral neck fracture. Metab Bone Dis Rel Res 4:85-93
12. Åkesson K, Lau K-HW, Baylink DJ (1997) Rational for active vitamin D analog therapy in senile osteoporosis. Calcif Tissue Int 60:100-105
13. Francis RM (1997) Is there a differential response to alfacalcidol and vitamin D in the treatment of osteoporosis? Calcif Tissue Int 60:111-114
14. Heikinehimo R, Inkovaara J, Harju E, Haavisto M, Kaarela R, Kataja J, Kokko A, Kolho L, Rajala S (1992) Annual injection of vitamin D and fractures in aged bones. Calcif Tissue Int 51:105-110
15. Toss G, Almqvist S, Larsson L, Zetterqvist H (1980) Vitamin D deficiency in welfare institutions for the aged. Acta Med Scand 208:87-89
16. Ooms ME, Lips P, Roos JC, van der Vijgh WJ, Popp-Snijders C, Bezemer PD, Bouter LM (1995) Vitamin D status and sex hormone-binding globulin: determinants of bone turnover and bone mineral density in elderly women. J Bone Miner Res 10:1177-1184
17. Khaw KT, Sneyd MJ, Compston J (1992) Bone density, parathyroid hormone and 25-hydroxyvitamin D concentrations in middle-aged women. Br Med J 305:273-277
18. Eastell R, Riggs BL (1997) Vitamin D and osteoporosis. In: Feldman D, Glorieux FH, Pike JW (eds) Vitamin D. Academic Press, San Diego, CA pp 695-711
19. Chapuy MC, Meunier PJ (1997) Vitamin D insufficiency in adults and the elderly. In: Feldman D, Glorieux FH, Pike JW (eds) Vitamin D. Academic Press, San Diego, CA pp 679-693
20. Quesada JM, Coopmans W, Ruiz B, Aljama P, Jans I, Bouillon R (1992) Influence of vitamin D on parathyroid function in the elderly. J Clin Endocrinol Metab 75:494-501
21. McKenna MJ (1992) Differences in vitamin D status between countries in young adults and the elderly. Am J Med 93:69-77
22. Thomas MK, Lloyd-Jones DM, Thadhani RJ, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL, Finkelstein JS (1998). Hypovitaminosis D in medical inpatients. N Engl J Med 338:777-783
23. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, Meunier PJ (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteoporosis Int 7:439-443
24. Epstein S, Bryce G, Hinman JW, Miller ON, Riggs BL, Hui SL, Johnston CC Jr (1986) The influence of age on bone mineral regulating hormones. Bone 7:421-425
25. Eastell R, Yergey AL, Vieira NE, Cedel SL, Kumar R, Riggs BL (1991) Interrelationship among vitamin D metabolism, true calcium absorption, parathyroid function, and age in women: evidence of an age-related intestinal resistance to 1,25-dihydroxyvitamin D action. J Bone Miner Res 6:125-132
26. Kinyamu HK, Gallagher JC, Petranick KM, Ryschon KL (1996) Effect of parathyroid hormone (hPTH[1-34]) infusion on serum 1,25-dihydroxyvitamin D and parathyroid hormone in normal women. J Bone Miner Res 11:1400-1405
27. Francis RM, Peacock M, Barkworth SA (1984) Renal impairment and its effects on calcium metabolism in elderly women. Age Ageing 13:14-20
28. Slovik DM, Daly MA, Potts JT, Neer RM (1984) Renal 1,25-dihydroxyvitamin D, phosphaturic, and cyclic-AMP responses to intravenous synthetic human parathyroid hormone (1-34) administration in normal subjects. Clin Endocrinol (Oxf) 20: 369-375
29. Prince RL, Dick IM, Lemmon J, Randell D (1997) The pathogenesis of age-related osteoporotic fracture: effects of dietary calcium deprivation. J Clin Endocrinol Metab 82:260-264
30. Slovik DM, Adams JS, Neer RM, Holick MF, Potts JT (1981) Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients. N Engl J Med 305:372-374
31. Ebeling PR, Sandgren ME, DiMagno EP, Lane AW, DeLuca HF, Riggs BL (1992) Evidence of an age-related decrease in intestinal responsiveness to vitamin D: relationship between serum 1,25-dihydroxy vitamin D and intestinal vitamin D receptor concentration in normal women. J Clin Endocrinol Metab 75:176-182
32. Dokoh S, Monta R, Fukunaga M, Yamamoto I, Torizuka K (1978) Competitive protein binding assay for 1,25-dihydroxyvitamin D in human plasma. Endocrinol Jpn 25: 431-436
33. Lund B, Sorensen OH, Lund B, Agner E (1982) Serum 1,25-dihydroxyvitamin D in normal subjects and in patients with postmenopausal osteopenia. Influence of age, renal function and oestrogen therapy. Horm Metab Res 14:271-274
34. 2 in elderly subjects. J Clin Endocrinol Metab 63:656-660
35. 3. Biochem J 316:361-371
36. Kinyamu HK, Gallagher JC, Prahl JM, DeLuca HF, Petranick KM, Lanspa SJ (1997) Association between intestinal vitamin D receptor, calcium absorption, and serum 1,25 dihydroxyvitamin D in normal young and elderly women. J Bone Miner Res 12:922-928
37. Utiger RD (1998) The need for more vitamin D. N Engl J Med 338:828-829
38. Delmez JA, Tindira C, Grooms P, Dusso A, Windus DW, Slatopolsky E (1989) Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium. J Clin Invest 83:1349-1355
39. Stauffer M, Baylink DJ, Wergedal J, Rich C (1973) Decreased bone formation and mineralization, and enhanced resorption in calcium-deficient rats. Am J Physiol 225:269-276
40. Rosen C, Donahue LR, Hunter S, Holick M, Kavookjian H, Kirschenbaum A, Mohan S, Baylink DJ (1992) The 24/25-kDa serum insulin-like growth factor binding protein is increased in elderly women with hip and spine fractures. J Clin Endocrinol Metab 74:24-27
41. Finkelman RD, Linkhart TA, Mohan S, Lau K-HW, Baylink DJ, Bell NH (1991) Vitamin D deficiency causes a selective reduction in deposition of transforming growth factor β in rat bone: possible mechanism for impaired osteoinduction. Proc Natl Acad Sci USA 88:3657-3660
42. Nicolas V, Prewett A, Bettica P, Mohan S, Finkelman RD, Baylink DJ, Farley JR (1994) Age-related decreases in insulin-like growth factor-I and transforming growth factor-β in femoral cortical bone from both men and women: implications for bone loss with aging. J Clin Endocrinol Metab 78:1011-1016
43. Boonen S, Aerssens J, Dequeker J, Nicholson P, Cheng XG, Lowet G, Verbeke G, Bouillon R (1997) Aging-associated decline in human femoral neck cortical and trabecular content of insulin-like growth factor I: potential implications for age-related (type II) osteoporotic fracture occurrence. Calcif Tissue Int 61:173-178
44. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, Rosen T, Lindstedt G, Lundberg PA, Wilske J, Bengtsson BÅ (1995) Serum intact parathyroid hormone in a random population sample of men and women: relationship to anthropometry, life-style factors, blood pressure and vitamin D. Calcif Tissue Int 56:104-108
45. Francis RM, Boyle IT, Moniz C, Sucliffe AM, Davis BS, Beastall GH, Cowan RA, Downes N (1996) A comparison of the effects of alfacalcidol treatment and vitamin D supplementation on calcium absorption in elderly women with vertebral fractures. Osteoporosis Int 6:284-290
46. Kinyamu HK, Gallagher JC, Balhom KE, Petranick KM, Rafferty KA (1997) Serum vitamin D metabolites and calcium absorption in normal young and elderly free-living women and in women living in nursing homes. Am J Clin Nutr 65: 790-797
47. 3. J Clin Endocrinol Metab 79: 211-216
48. Åkesson K, Ljunghall S, Jonsson B, Sernbo I, Johnell O, Gärdsell P, Obrant KJ (1995) Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: a retrospective and prospective population-based study of women. J Bone Miner Res 10:1823-1829
49. Taguchi Y, Gorai I, Zhang MG, Chaki O, Nakayama M, Minaguchi H (1998) Differences in bone resorption after menopause in Japanese women with normal or low bone mineral density: quantitation of urinary cross-linked N-telopeptides. Calcif Tissue Int 62:395-399
50. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD (1996) Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 11:337-434
51. 3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327:1637-1642
52. 2D. Am J Clin Nutr 52: 701-706
53. Olson EB, DeLuca HF (1969) 25-Hydroxycholecalciferol: direct effect on calcium transport. Science 165:405-407
54. Colodro IH, Brickman AS, Coburn JW, Osborn TW, Norman AW (1978) Effect of 25-hydroxy-vitamin D, on intestinal absorption of calcium in normal man and patients with renal failure. Metabolism 27:745-753
55. Heaney RP, Recker RR, Stegman MR, Moy AJ (1989) Calcium absorption in women: relationship to calcium intake, estrogen status and age. J Bone Miner Res 4:469-475
56. Schwartzman MS, Franck WA (1987) Vitamin D toxicity complicating the treatment of senile, postmenopausal, and glucocorticoid-induced osteoporosis. Four case reports and a critical commentary on the use of vitamin D in these disorders. Am J Med 82:224-230
57. 3. Maturitas 22:55-61
58. 3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy. Eur J Endocrinol 137:495-502
59. Chapuy MC, Chapuy P, Thomas JL, Hazard MC, Meunier PJ (1996) Biochemical effects of calcium and vitamin D supplementation in elderly, institutionalized, vitamin D-deficient patients. Rev Rhum Engl Ed 63:135-140
60. Dawson-Hughes B, Harris SS, Krall EA, Dallai GE (1997) Effects of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337:670-676
61. Dawson-Hughes B, Dallal GE, Krall EA, Harris S, Sokoll LJ, Falconer G (1991) Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Intern Med 115:505-512
62. Nordin BEC, Baker MR, Horsman A, Peacock M (1985) A prospective trial of the effect of vitamin D supplementation on metacarpal bone loss in elderly women. Am J Clin Nutr 42: 470-474
63. Lips P, Graafmans WC, Ooms ME, Bezemer PD, Bouter LM (1996) Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial. Ann Intern Med 124:400-406
64. Orwoll ES, Oviatt SK, McClung MR, Deftos LJ, Sexton G (1990) The rate of bone mineral loss in normal men and the effects of calcium and cholecalciferol supplementation. Ann Intern Med 112:29-34
65. Eastell R (1998) Treatment of postmenopausal osteoporosis. N Engl J Med 338:736-746
66. Ranstam J, Kanis JA (1995) Influence of age and body mass on the effects of vitamin D on hip fracture risk. Osteoporosis Int 5:450-454
67. Graafmans WC, Lips P, Ooms ME, van Leeuwen JP, Pols HA, Uitterlinden AG (1997) The effect of vitamin D supplementation on the bone mineral density of the femoral neck is associated with vitamin D receptor genotype. J Bone Miner Res 12:1241-1245
68. Nakamura T (1997) The importance of genetic and nutritional factors in responses to vitamin D and its analogs in osteoporotic patients. Calcif Tissue Int 60:119-123
69. 3. Eur J Clin Invest 13:391-396
70. Chapuy MC, Chapuy P, Meunier PJ (1987) Calcium and vitamin D supplements: effects on calcium metabolism in elderly people. Am J Clin Nutr 46:324-328
71. Lips P, van Ginkel FC, Jongen MJM, Rubertus A, van der Vijgh WJF, Netelenbos JC (1987) Determinants of vitamin D status in patients with hip fracture and elderly control subjects. Am J Clin Nutr 46:1005-1010
72. 3 on circulating levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D. Calcif Tissue Int 62:26-30
73. Tilyard MW, Spears GFS, Thompson J, Dovey S (1992) Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 326:357-362
74. 3 on calcium balance and bone turnover and its effect on vertebral fracture rate. Metabolism 39 (suppl 1): 30-34
75. Aloia JF, Vaswani A, Yeh JK, Ellis K, Yasumura S, Cohn SH (1988) Calcitriol in the treatment of postmenopausal osteoporosis. Am J Med 84:401-408
76. Gallagher JC, Goldgar D (1990) Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol: a randomized controlled study. Ann Intern Med 113:649-655
77. Ott SM, Chesnut CH III (1989) Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Intern Med 110:267-274
78. Falch JA, Odegaard OR, Finnanger AM, Matheson I (1987) Postmenopausal osteoporosis: no effect of three years treatment with 1,25-dihydroxycholecalciferol. Acta Med Scand 221:199-204
79. 3) on osteoporosis: multicenter double-blind study. J Clin Exp Med 123:958-973
80. Fujita T, Matsui T, Nakao Y, Shiozawa S, Imai Y (1990) Cytokines and osteoporosis. Ann NY Acad Sci 587:371-375
81. 3. J Bone Miner Metab 10:50-54
82. 3. Bone Miner 3:47-52
83. 3. Bone Miner 20:223-234
84. 3) and calcium in osteoporosis. Clin Orthop 300:241-247
85. 3 on bone mineral density and incidence of fracture: a placebo-controlled, double-blind prospective study. Endocr J 43:211-220
86. Dambacher MA, Kranich M, Schacht E, Neff M (1997) Can the fast bone loss in osteoporotic and osteopenic patients be stopped with active vitamin D metabolites? Calcif Tissue Int 60:115-118
87. Need AG, Morris HA, Horowitz M, Nordin NE (1997) The response to calcitriol therapy in postmenopausal osteoporotic women is a function of initial calcium absorptive status. Calcif Tissue Int 61:6-9
88. 3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis. Proc Natl Acad Sci USA 79:3325-3329
89. Gallacher SJ, Cowan RA, Fraser WD, Logue FC, Jenkins A, Boyle IT (1994) Acute effects of intravenous 1α-hydroxycholecalciferol on parathyroid hormone, osteocalcin and calcitriol in man. Eur J Endocrinol 130:141-151
90. 3 treatment decreases bone turnover and modulates calcium-regulating hormones in early postmenopausal women. Bone 20:557-562
91. 3 and estrogen therapy on cortical bone mechanical properties in the ovariectomized rat model. Endocrinology 137:1358-1364
92. 3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcif Tissue Int 54:370-376
93. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF (1996) Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β. Nat Med 2:1132-1136
94. 3, transforming growth factor β1, calcium, and ultraviolet B radiation induce apoptosis in cultured human keratinocytes. J Invest Dermatol 109:276-282